CIBC Asset Management’s CONMED CNMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-3,067
Closed -$210K 1195
2024
Q4
$210K Buy
+3,067
New +$214K ﹤0.01% 1100
2023
Q3
Sell
-1,981
Closed -$269K 1059
2023
Q2
$269K Sell
1,981
-38
-2% -$4.64K ﹤0.01% 841
2023
Q1
$210K Buy
+2,019
New +$195K ﹤0.01% 920
2022
Q2
Sell
-2,200
Closed -$327K 1316
2022
Q1
$327K Hold
2,200
﹤0.01% 1009
2021
Q4
$312K Buy
2,200
+80
+4% +$11.3K ﹤0.01% 1050
2021
Q3
$277K Buy
+2,120
New +$277K ﹤0.01% 1061
2021
Q1
Sell
-2,227
Closed -$249K 1335
2020
Q4
$249K Buy
+2,227
New +$211K ﹤0.01% 995

Other funds holding CNMD

CIBC Asset Management's CNMD Position: Q1 2025 in Review

CIBC Asset Management sold out of CONMED (CNMD) in Q1 2025, closing a stake of 3,067 shares — an estimated $210K sold.

CIBC Asset Management first reported a position in CNMD in Q4 2020 and held it in 7 quarters. The position peaked at $327K in Q1 2022. 280 funds tracked by Wall St. Rank hold CNMD as of Q1 2025.

  • CIBC Asset Management reported no remaining CONMED position as of Q1 2025 after selling out during the quarter.
  • CIBC Asset Management sold 3,067 CONMED shares in Q1 2025, an estimated $210K.
  • CIBC Asset Management first reported a position in CONMED in Q4 2020 and held it in 7 quarters.
  • CIBC Asset Management's CONMED position peaked at $327K in Q1 2022.
  • 280 funds tracked by Wall St. Rank held CONMED as of Q1 2025.

Based on CIBC Asset Management's 13F filing for Q1 2025, filed 13 May 2025.